Skip to main content
OpenTrials
Completed

NCT Number: NCT03881046

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hamide Sahin

Ankara, 06105, Turkey (Türkiye)

About this study

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased.

Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement.

This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • To have a diagnosis of lung cancer
  • Complete chemotherapy
  • Complete radiotherapy
  • Coopere,
  • Accepts participation in the study will be included in the study

Exclusion criteria

  • Neurological, cognitive or orthopedic diseases that affect the measurements
  • Acute infection
  • Individuals with other chronic diseases that may affect their walking will not be included in the study

Treatment and study plan

Primary outcomes

  1. Activities Of Daily Living

    Time frame: 1st day

    Daily Living Activities will be evaluated using the Londrina Protocol.The protocol consists of 5 stations. Stations are including organizing books on the table, 18 meters walking by carrying 10% of body weight symmetrically, arranging books by putting them on shelves, hanging the laundry in the laundry basket and walking 18 meters. İndividual will do these activities at his own pace and the time will be recorded at the end.

Secondary outcomes

  1. Life Quality

    Time frame: 1st Day

    Quality of life will be measured using Core Quality of Life Questionnaire (EORTC QLQ-C30) The questionnaire consists of 30 questions and provides information on quality of life and symptoms.

  2. Peripheral Muscle Strength

    Time frame: 1st Day

    Muscle strength will be evaluated by force measuring dynamometer device 3 times. M.Quadriceps Femoris, shoulder abduction, shoulder flexion, elbow flexion, elbow extension and hand grip strength of all cases will be measured.

  3. Dyspnoea

    Time frame: 1st Day

    Dyspnoea will be evaluated using the Medical Research Council Dyspnoea Scale. The Medical Research Council Dyspnoea Scale has a score of 0-4. İn this scoring system 0 indicates that there is no dyspnoea, whereas 4 indicates that the dyspnoea is too high.

  4. Respiratory Functions

    Time frame: 1st Day

    Respiratory functions will be measured by spirometric measurement. This measurement will give us FEV1 FVC FEV1 / FVC values.

  5. Exercise Capacity

    Time frame: 1st Day

    6 Minute walk test will be used.In the test, the person will be asked to walk as fast as possible in a 30-meter corridor and the walking distance will be recorded in 6 minutes.

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Mar 19, 2019
Registry last updated
Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.